VX-880 reduces or eliminates the need for insulin use in patients with type 1 diabetes (T1D). Islets derived from VX-880 stem cells can restore physiological islet function and blood glucose control.

The research team successfully established a robust and scalable human iPSC 4R Tau disease model.

This study successfully captured two new types of totipotent cells by programming human pluripotent stem cells by inhibiting splicing weight for the first time.

Cell products are expected to be included in the ranks of advanced therapeutic drugs!

The early results of the first human trial at Stanford University School of Medicine show that transcranial stereotactic local injection of neural stem cells derived from human embryos is safe.

The Bio-protocol Journal published online a method article entitled "Generation of Skeletal Muscle Organoids from Human Pluripotent Stem Cells" by the Holm Zaehres team of Ruhr-Universit ä t Bochum in Bochum, Germany.

A phase I clinical study on the safety and preliminary efficacy of transnasal transplantation of human neural stem cells in the treatment of Parkinson's disease has been successfully carried out.

Epigenetic reprogramming resets the epigenetic memory of parents and differentiates primordial germ cells (PGCs) into premitotic spermatogonia or oogonia to ensure sex-differentiated germ cell development and totipotency.